# DKK4

## Overview
DKK4, or dickkopf WNT signaling pathway inhibitor 4, is a gene that encodes a secreted protein involved in the regulation of the Wnt signaling pathway, a critical pathway for cell proliferation, differentiation, and migration. The DKK4 protein is categorized as a signaling inhibitor and is characterized by its two cysteine-rich domains, which are essential for its function in binding to the Wnt co-receptors LRP5 and LRP6. This binding inhibits the Wnt/β-catenin signaling pathway, thereby playing a crucial role in embryonic development and tissue homeostasis (Krupnik1999Functional; Niehrs2006Function). DKK4's regulatory functions extend to various physiological processes, including segmentation, limb polarity, and brain development, and its dysregulation is implicated in diseases such as cancer and bone density disorders (Krupnik1999Functional; Li2024Colorectal). Understanding the molecular interactions and clinical implications of DKK4 provides valuable insights into its potential as a therapeutic target.

## Structure
DKK4 is a member of the dickkopf family of proteins, characterized by its role in inhibiting the WNT signaling pathway. The primary structure of DKK4 includes two cysteine-rich domains (CRDs), known as CRD1 and CRD2, each containing five disulfide bonds, which are crucial for its function (Krupnik1999Functional; Wen2023Molecular). These domains are important for binding to the Wnt co-receptor LRP5/6, thereby regulating Wnt signal transduction (Wen2023Molecular).

The secondary structure of DKK4 is not explicitly detailed in the available literature, but it is known that the protein undergoes proteolytic processing, which results in the cleavage of the second cysteine-rich domain (Krupnik1999Functional). This processing suggests a level of structural complexity that may involve alpha helices and beta sheets, typical of proteins with such domains.

DKK4 does not have N-glycosylation sites, as indicated by its unchanged mobility after N-glycanase treatment, suggesting that glycosylation is not a post-translational modification for this protein (Krupnik1999Functional). The protein's expression patterns are tissue-specific, indicating potential splice variant isoforms, although specific isoforms are not detailed in the provided context (Krupnik1999Functional).

## Function
DKK4 (dickkopf WNT signaling pathway inhibitor 4) is a secreted protein that plays a significant role in modulating the Wnt signaling pathway, which is crucial for various developmental and physiological processes. DKK4 functions as an antagonist of the Wnt/β-catenin signaling pathway by binding to the Wnt coreceptors LRP5 and LRP6, thereby inhibiting the pathway's activation (Niehrs2006Function). This inhibition is important for regulating cell proliferation, differentiation, and migration, which are essential for embryonic development and tissue homeostasis (Krupnik1999Functional).

In healthy human cells, DKK4 is involved in processes such as segmentation, limb polarity, and brain development by modulating Wnt signaling (Krupnik1999Functional). The protein is secreted into the extracellular space, where it interacts with its target receptors to exert its regulatory effects (Krupnik1999Functional). DKK4 undergoes proteolytic processing, potentially by furin-type proteases, and does not contain N-glycosylation sites, as indicated by its unchanged mobility after N-glycanase treatment (Krupnik1999Functional). These molecular activities highlight DKK4's role in maintaining cellular functions and development by influencing the Wnt signaling pathway.

## Clinical Significance
DKK4 (dickkopf WNT signaling pathway inhibitor 4) plays a significant role in the regulation of the WNT signaling pathway, which is essential for cell proliferation and differentiation. Alterations in DKK4 expression or mutations can be associated with various diseases. In cancer, changes in DKK4 expression may influence tumor growth and metastasis. The WNT signaling pathway, which DKK4 inhibits, is often dysregulated in cancer, leading to uncontrolled cell proliferation. Therefore, aberrant DKK4 activity can contribute to the progression of certain cancers by affecting the balance of cell growth and differentiation.

DKK4 is also implicated in bone density disorders due to its involvement in bone formation and remodeling. The WNT signaling pathway is crucial for maintaining bone homeostasis, and disruptions in DKK4 expression can lead to imbalances in bone density. This can result in conditions such as osteoporosis, where bone resorption outpaces bone formation, leading to weakened bones and increased fracture risk.

Overall, the clinical significance of DKK4 is primarily linked to its regulatory role in the WNT signaling pathway, with implications for both oncological and bone-related conditions. Understanding the precise mechanisms by which DKK4 influences these diseases could provide insights into potential therapeutic targets.

## Interactions
DKK4, a member of the Dickkopf family, is known for its role as an inhibitor in the Wnt/β-catenin signaling pathway. It interacts with the LRP5/6 co-receptors, preventing the formation of the FRIZZLED-LRP6 complex, which is essential for stabilizing β-catenin and activating the Wnt pathway (Li2024Colorectal). DKK4 also forms a complex with Kremen proteins and LRP5/6, leading to the endocytosis and removal of LRP5/6 from the plasma membrane, thereby inactivating the Wnt/β-catenin pathway (Li2024Colorectal).

In colorectal cancer (CRC), DKK4 is secreted by cancer cells and has been shown to bind to LRP6, leading to the phosphorylation of β-catenin at specific serine and threonine residues (Ser33/Ser37/Thr41) in fibroblasts. This phosphorylation enhances the ubiquitination and degradation of β-catenin, reducing its protein levels and affecting fibroblast transformation (Li2024Colorectal). The interactions of DKK4 with β-catenin and other proteins like GSK3β and ubiquitin are crucial in modulating β-catenin signaling pathways, influencing tumor growth and metastasis (Li2024Colorectal). These interactions highlight DKK4's role in both inhibiting and modulating the Wnt/β-catenin signaling pathway, impacting cancer progression and fibroblast transformation.


## References


[1. (Krupnik1999Functional) Valery E. Krupnik, John D. Sharp, Chian Jiang, Keith Robison, Troy W. Chickering, Lakshmi Amaravadi, Diane E. Brown, Deborah Guyot, Gail Mays, Kevin Leiby, Belle Chang, Thao Duong, Andrew D.J. Goodearl, David P. Gearing, Sergei Y. Sokol, and Sean A. McCarthy. Functional and structural diversity of the human dickkopf gene family. Gene, 238(2):301–313, October 1999. URL: http://dx.doi.org/10.1016/s0378-1119(99)00365-0, doi:10.1016/s0378-1119(99)00365-0. This article has 375 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(99)00365-0)

[2. (Wen2023Molecular) Binhong Wen, Sile Hu, Jun Yin, Jianghong Wu, and Wenrui Guo. Molecular evolution and protein structure variation of dkk family. Genes, 14(10):1863, September 2023. URL: http://dx.doi.org/10.3390/genes14101863, doi:10.3390/genes14101863. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14101863)

[3. (Li2024Colorectal) Xue Li, Yulin Chen, Ran Lu, Min Hu, Lei Gu, Qiaorong Huang, Wentong Meng, Hongyan Zhu, Chuanwen Fan, Zongguang Zhou, and Xianming Mo. Colorectal cancer cells secreting dkk4 transform fibroblasts to promote tumour metastasis. Oncogene, 43(20):1506–1521, March 2024. URL: http://dx.doi.org/10.1038/s41388-024-03008-1, doi:10.1038/s41388-024-03008-1. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-024-03008-1)

[4. (Niehrs2006Function) C Niehrs. Function and biological roles of the dickkopf family of wnt modulators. Oncogene, 25(57):7469–7481, December 2006. URL: http://dx.doi.org/10.1038/sj.onc.1210054, doi:10.1038/sj.onc.1210054. This article has 792 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1210054)